Loading
CARsgen Therapeutics Holdings Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Wang Huamao, was filed 27 May 2026.
Insider Decl.
136
Thresholds
n/a
Buy Volume
€2M
125 ops. · all time
Sell Volume
n/a
6 ops. · all time
Who traded when
BuySaleGuo Huaqing19 buys2 sales
Li Zonghai18 buys2 sales
Wang Huamao18 buys2 sales
Jiang Hua5 buys
Guo Bingsen2 buys
Since the insiders bought
- -19.4%Entry HK$14.89 · Close 21 Oct 2026 HK$12.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,133 of 26,250 companies
30.2
score / 100
Value26
Quality34
FCF yld-3.6%
Earn yld-1.4%
EV/EBITDA·
ROE-9.6%
Gross mgn64%
Net mgn-78%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$11.99
Analyst consensus
2 analysts2.67/5
HK$13.96Target HK$18.48(+54%)HK$23.01
Income statement
RevenueHK$125.7M
Gross profitHK$79.9M64% margin
EBITDA-HK$66.5M-53% margin
Net income-HK$97.9M-65.3% margin
Valuation
P/Book5.2x
Beta0.35
Balance sheet & cash
Market capHK$6.8B
Total debtHK$61.2M
Free Cash Flow-HK$243M
Debt / Equity7%
Profitability & ownership
ROE-9.6%
ROA-8.9%
% insiders36.7%
% institutions11.0%
Last declaration on 4 August 2026
Declarations136 total
7,228,000 sharesShareXHKGHKEX:DA20260804E00169
7,228,000 sharesShareXHKGHKEX:DA20260804E00154
7,228,000 sharesShareXHKGHKEX:DA20260804E00160
23,700,000 sharesShareXHKGHKEX:DA20260527E00158
Canonical exit: 24 Aug 2026 (T+90)
23,700,000 sharesShareXHKGHKEX:DA20260527E00165
Canonical exit: 24 Aug 2026 (T+90)
23,700,000 sharesShareXHKGHKEX:DA20260527E00172
23,700,000 sharesShareXHKGHKEX:DA20260527E00156
23,700,000 sharesShareXHKGHKEX:DA20260527E00161
23,700,000 sharesShareXHKGHKEX:DA20260527E00173
Canonical exit: 24 Aug 2026 (T+90)
180,000 sharesShareXHKGHKEX:DA20260312E00066
Canonical exit: 7 Jun 2026 (T+90)
20,000 sharesShareXHKGHKEX:DA20251224E00211
Canonical exit: 22 Mar 2026 (T+90)
20,000 sharesShareXHKGHKEX:DA20251224E00213
Canonical exit: 22 Mar 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20251224E00206
Canonical exit: 19 Mar 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20251224E00208
Canonical exit: 19 Mar 2026 (T+90)
20,000 shares@ HK$14.931.4% of flowShareXHKGHKEX:DA20251224E00210
Canonical exit: 22 Mar 2026 (T+90)
30,000 shares@ HK$15.092.2% of flowShareXHKGHKEX:DA20251224E00027
Canonical exit: 19 Mar 2026 (T+90)
18,000 sharesShareXHKGHKEX:DA20251219E00330
Canonical exit: 18 Mar 2026 (T+90)
18,000 sharesShareXHKGHKEX:DA20251219E00332
Canonical exit: 18 Mar 2026 (T+90)
1,476,000 sharesShareXHKGHKEX:DA20251219E00298
Canonical exit: 17 Mar 2026 (T+90)
1,476,000 sharesShareXHKGHKEX:DA20251219E00292
Canonical exit: 17 Mar 2026 (T+90)
1,476,000 sharesShareXHKGHKEX:DA20251219E00295
Canonical exit: 17 Mar 2026 (T+90)
18,000 shares@ HK$14.521.3% of flowShareXHKGHKEX:DA20251219E00334
Canonical exit: 18 Mar 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20251216E00363
Canonical exit: 15 Mar 2026 (T+90)
30,000 sharesShareXHKGHKEX:DA20251216E00365
Canonical exit: 15 Mar 2026 (T+90)
18,500 sharesShareXHKGHKEX:DA20251216E00362
Canonical exit: 12 Mar 2026 (T+90)
25 of 136 declarations
About CARsgen Therapeutics Holdings Ltd. - B
CARsgen Therapeutics Holdings Ltd. - B, a health care company listed on the Hong Kong stock exchange and valued at HKD 6.8 billion, shows an almost exclusively buy-side profile: 125 purchases against 6 sales, or 95% of open-market trades. Only 27 purchases carry an amount, EUR 2,288,000 in total (median EUR 54,899), and no sale does.
The largest purchase, EUR 579,113, is by Guo Huaqing (Director) on April 30, 2024, followed by the same filer with EUR 178,129 on May 30, 2024 and EUR 164,644 on June 4, 2024. Guo Huaqing, Wang Huamao and Li Zonghai, all directors, file 39, 37 and 36 filings, of which 35, 34 and 33 are purchases. On September 18, 2025, all 5 directors on the record bought on the same day.
Read moreShow less
Insiders hold 36.7% of the capital. The record has 136 filings: 51 in 2024 and 57 in 2025, against 4 to 9 a year from 2021 to 2023. Over twelve months: 56 filings, 50 purchases, 6 sales. The 27 purchases with a result have a 90-day median of minus 19%, with 30% positive (recorded past results, not a forecast).
